# Marker Therapeutics (MRKR) — Analyst Forecast

MRKR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mrkr/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Dec 8, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $10.00 |
| Apr 1, 2025 | WBB Securities | Maintained | Strong Buy | $12.50 |
| Mar 5, 2025 | Canaccord Genuity | Initiated Coverage | Buy | $8.00 |
| Oct 21, 2024 | Ladenburg Thalmann | Maintained | Buy | $19.00 |
| Apr 30, 2024 | Ladenburg Thalmann | Initiated Coverage | Buy | $11.00 |

## Frequently Asked Questions

### What is the latest analyst rating on MRKR?

On Dec 8, 2025, HC Wainwright & Co. initiated coverage of Marker Therapeutics at Buy with a price target of $10.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).